PFBT
FATE icon

Parkside Financial Bank & Trust’s Fate Therapeutics FATE Stock Holding History

Parkside Financial Bank & Trust’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81K Hold
670
– – ﹤0.01% 2217
2026
Q1 		$804 Hold
670
– – ﹤0.01% 2428
2025
Q4 		$659 Hold
670
– – ﹤0.01% 2488
2025
Q3 		$845 Hold
670
– – ﹤0.01% 2357
2025
Q2 		$751 Buy
+670
New +$779 ﹤0.01% 2358

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Parkside Financial Bank & Trust's FATE Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Fate Therapeutics (FATE) position steady in Q2 2026 at 670 shares worth $1.81K. The position accounts for ﹤0.01% of the portfolio, ranked #2217.

Parkside Financial Bank & Trust first reported a position in FATE in Q2 2025 and has held it in 5 quarters since. 156 funds tracked by Wall St. Rank hold FATE as of Q2 2026.

  • Parkside Financial Bank & Trust held 670 shares of Fate Therapeutics worth $1.81K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Fate Therapeutics share count unchanged in Q2 2026.
  • Fate Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2217 holding.
  • Parkside Financial Bank & Trust first reported a position in Fate Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 156 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.